The Use of Neuroimaging to Assess Associations Among Diet, Nutrients, Metabolic Syndrome, and Alzheimer's Disease.
暂无分享,去创建一个
M. Battino | F. Pistollato | I. Elío | F. Giampieri | Francesca Pistollato | Francesca Giampieri | Maurizio Battino | Sandra Sumalla Cano | Iñaki Elio | Manuel Masias Vergara
[1] A. Kowaltowski,et al. Dietary restriction in cerebral bioenergetics and redox state☆ , 2014, Redox biology.
[2] Xue Hua,et al. Homocysteine effects on brain volumes mapped in 732 elderly individuals , 2011, Neuroreport.
[3] I. Bauer,et al. Acute Effects of Different Multivitamin Mineral Preparations with and without Guaraná on Mood, Cognitive Performance and Functional Brain Activation , 2013, Nutrients.
[4] Y. Dinçer,et al. Alzheimer's disease and epigenetic diet , 2014, Neurochemistry International.
[5] M. Kamal,et al. Fighting Alzheimer's disease and type 2 diabetes: pathological links and treatment strategies. , 2014, CNS & neurological disorders drug targets.
[6] Yuan Feng,et al. Aberrant Brain Functional Connectivity Related to Insulin Resistance in Type 2 Diabetes: A Resting-State fMRI Study , 2014, Diabetes Care.
[7] T. Anekonda. Resveratrol—A boon for treating Alzheimer's disease? , 2006, Brain Research Reviews.
[8] M. D. de Leon,et al. Physical Activity, Mediterranean Diet and Biomarkers-Assessed Risk of Alzheimer’s: A Multi-Modality Brain Imaging Study , 2014, Advances in molecular imaging.
[9] C. Mun,et al. Apolipoprotein E genotype modulates effects of vitamin B12 and homocysteine on grey matter volume in Alzheimer's disease , 2016, Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society.
[10] Lucia Kerti,et al. Effects of Resveratrol on Memory Performance, Hippocampal Functional Connectivity, and Glucose Metabolism in Healthy Older Adults , 2014, The Journal of Neuroscience.
[11] O. Ukoumunne,et al. ¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). , 2014, The Cochrane database of systematic reviews.
[12] J. Blass. Mediterranean Diet and Mild Cognitive Impairment , 2009 .
[13] W. Klunk,et al. Development of positron emission tomography β-amyloid plaque imaging agents. , 2012, Seminars in nuclear medicine.
[14] H. Braak,et al. Where, when, and in what form does sporadic Alzheimer's disease begin? , 2012, Current opinion in neurology.
[15] A. Martí,et al. A 3 years follow-up of a Mediterranean diet rich in virgin olive oil is associated with high plasma antioxidant capacity and reduced body weight gain , 2009, European Journal of Clinical Nutrition.
[16] M. Sabbagh,et al. Are certain lifestyle habits associated with lower Alzheimer's disease risk? , 2010, Journal of Alzheimer's disease : JAD.
[17] Robert A. Gross,et al. Higher normal fasting plasma glucose is associated with hippocampal atrophy: The PATH Study , 2012 .
[18] S. Rapoport. Brain arachidonic and docosahexaenoic acid cascades are selectively altered by drugs, diet and disease. , 2008, Prostaglandins, leukotrienes, and essential fatty acids.
[19] Sterling C. Johnson,et al. Calorie Restriction Reduces the Influence of Glucoregulatory Dysfunction on Regional Brain Volume in Aged Rhesus Monkeys , 2012, Diabetes.
[20] P. Thompson,et al. Regular fish consumption and age-related brain gray matter loss. , 2014, American journal of preventive medicine.
[21] D. K. Johnson,et al. Insulin resistance and gray matter volume in neurodegenerative disease , 2014, Neuroscience.
[22] A. McKinney,et al. Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer's disease , 2010 .
[23] L. Tan,et al. Resveratrol as a Therapeutic Agent for Alzheimer's Disease , 2014, BioMed research international.
[24] Ronald C Petersen,et al. Association of mediterranean diet with mild cognitive impairment and Alzheimer's disease: a systematic review and meta-analysis. , 2014, Journal of Alzheimer's disease : JAD.
[25] P. Kamphuis,et al. Targeting synaptic dysfunction in Alzheimer's disease by administering a specific nutrient combination. , 2013, Journal of Alzheimer's disease : JAD.
[26] Cécile Proust-Lima,et al. Plasma long-chain omega-3 fatty acids and atrophy of the medial temporal lobe , 2012, Neurology.
[27] Karen F Berman,et al. The neurobiology of Alzheimer disease defined by neuroimaging. , 2012, Current opinion in neurology.
[28] Carole Dufouil,et al. Plasma lipids and cerebral small vessel disease , 2014, Neurology.
[29] G. Kemmler,et al. Conversion from mild cognitive impairment to dementia: Influence of folic acid and vitamin B12 use in the vita cohort , 2012, The journal of nutrition, health & aging.
[30] Cornelis J. Stam,et al. The Effect of Souvenaid on Functional Brain Network Organisation in Patients with Mild Alzheimer’s Disease: A Randomised Controlled Study , 2014, PloS one.
[31] L. Donini,et al. Nutritional status determinants and cognition in the elderly. , 2007, Archives of gerontology and geriatrics.
[32] Yaakov Stern,et al. Physical activity, diet, and risk of Alzheimer disease. , 2009, JAMA.
[33] Abderrahim Oulhaj,et al. Homocysteine-Lowering by B Vitamins Slows the Rate of Accelerated Brain Atrophy in Mild Cognitive Impairment: A Randomized Controlled Trial , 2010, PloS one.
[34] S. Ferreira,et al. Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer's disease , 2014, Alzheimer's & Dementia.
[35] A. Lerner. Amyloid imaging , 2013, Neurology.
[36] A. Kontush,et al. Vitamin E in Neurodegenerative Disorders: Alzheimer's Disease , 2004, Annals of the New York Academy of Sciences.
[37] Ashley R. Morgan,et al. Acute effect of a high nitrate diet on brain perfusion in older adults. , 2011, Nitric oxide : biology and chemistry.
[38] K. Shpanskaya,et al. Impact of 18F-florbetapir PET imaging of β-amyloid neuritic plaque density on clinical decision-making , 2014, Neurocase.
[39] S. M. de la Monte,et al. Brain metabolic dysfunction at the core of Alzheimer's disease. , 2014, Biochemical pharmacology.
[40] S. Rapoport,et al. Imaging brain signal transduction and metabolism via arachidonic and docosahexaenoic acid in animals and humans , 2012, Brain Research Bulletin.
[41] Shankar Vallabhajosula,et al. Nutrient intake and brain biomarkers of Alzheimer's disease in at-risk cognitively normal individuals: a cross-sectional neuroimaging pilot study , 2014, BMJ Open.
[42] Cornelis J Stam,et al. Efficacy of Souvenaid in mild Alzheimer's disease: results from a randomized, controlled trial. , 2012, Journal of Alzheimer's disease : JAD.
[43] R. Lamuela-Raventós,et al. Mediterranean diet and oxidation: nuts and olive oil as important sources of fat and antioxidants. , 2011, Current topics in medicinal chemistry.
[44] U. Broedl,et al. Adipokines and Insulin Resistance , 2008, Molecular medicine.
[45] P. Wolf,et al. The relation of dietary choline to cognitive performance and white-matter hyperintensity in the Framingham Offspring Cohort. , 2011, The American journal of clinical nutrition.
[46] J. Grimley Evans,et al. Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people. , 2008, The Cochrane database of systematic reviews.
[47] C. Murphy. The Chemical Senses and Nutrition in Older Adults , 2008, Journal of nutrition for the elderly.
[48] Kerry Jones,et al. Vitamin D and cognitive function , 2012, Scandinavian journal of clinical and laboratory investigation. Supplementum.
[49] Lars Bäckman,et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial , 2015, The Lancet.
[50] G. Bigford,et al. Supplemental substances derived from foods as adjunctive therapeutic agents for treatment of neurodegenerative diseases and disorders. , 2014, Advances in nutrition.
[51] C. Chen,et al. Impacts of hyper-homocysteinemia and white matter hyper-intensity in Alzheimer's disease patients with normal creatinine: an MRI-based study with longitudinal follow-up. , 2010, Current Alzheimer research.
[52] The S-Connect study: results from a randomized, controlled trial of Souvenaid in mild-to-moderate Alzheimer’s disease , 2013, Alzheimer's Research & Therapy.
[53] Yaakov Stern,et al. Mediterranean diet, Alzheimer disease, and vascular mediation. , 2006, Archives of neurology.
[54] P. Scheltens,et al. Efficacy of a medical food on cognition in Alzheimer’s Disease: Results from secondary analyses of a randomized, controlled trial , 2011, The journal of nutrition, health & aging.
[55] C. Duyckaerts,et al. Alzheimer disease models and human neuropathology: similarities and differences , 2007, Acta Neuropathologica.
[56] S. Arlt,et al. Effect of One-Year Vitamin C- and E-Supplementation on Cerebrospinal Fluid Oxidation Parameters and Clinical Course in Alzheimer’s Disease , 2012, Neurochemical Research.
[57] J. Jhamandas,et al. Islet amyloid polypeptide (IAPP): a second amyloid in Alzheimer's disease. , 2014, Current Alzheimer research.
[58] Allan Reiss,et al. Fasting plasma insulin and the default mode network in women at risk for Alzheimer's disease , 2013, Neurobiology of Aging.
[59] Sterling C. Johnson,et al. Low cerebral blood flow is associated with lower memory function in metabolic syndrome , 2012, Obesity.
[60] A. Brickman,et al. Mediterranean diet and magnetic resonance imaging–assessed cerebrovascular disease , 2011, Annals of neurology.
[61] Thomas E. Nichols,et al. Preventing Alzheimer’s disease-related gray matter atrophy by B-vitamin treatment , 2013, Proceedings of the National Academy of Sciences.
[62] J. Trojanowski,et al. Tau-mediated neurodegeneration in Alzheimer's disease and related disorders , 2007, Nature Reviews Neuroscience.
[63] J. Kaye,et al. Nutrient biomarker patterns, cognitive function, and MRI measures of brain aging , 2011, Neurology.
[64] Sterling C. Johnson,et al. Calorie restriction reduces psychological stress reactivity and its association with brain volume and microstructure in aged rhesus monkeys , 2012, Psychoneuroendocrinology.
[65] P. Scheltens,et al. Utility of imaging for nutritional intervention studies in Alzheimer's disease. , 2011, European journal of pharmacology.
[66] A. Hofman,et al. Total antioxidant capacity of the diet and major neurologic outcomes in older adults , 2013, Neurology.
[67] Liang Shen,et al. Associations between Homocysteine, Folic Acid, Vitamin B12 and Alzheimer's Disease: Insights from Meta-Analyses. , 2015, Journal of Alzheimer's disease : JAD.
[68] M. Martínez-González,et al. Mediterranean Diet Inversely Associated With the Incidence of Metabolic Syndrome , 2007, Diabetes Care.
[69] J. Silverman,et al. Cardiovascular risk factors for Alzheimer's disease. , 2007, The American journal of geriatric cardiology.
[70] Tyler E. Benedum,et al. Florbetapir f-18: a histopathologically validated Beta-amyloid positron emission tomography imaging agent. , 2011, Seminars in nuclear medicine.
[71] K. Bürger,et al. Taste in mild cognitive impairment and Alzheimer’s disease , 2010, Journal of Neurology.
[72] P. Amiano,et al. Diet, cognition, and Alzheimer’s disease: food for thought , 2014, European Journal of Nutrition.
[73] F. D. Felice. Alzheimer’s disease and insulin resistance: translating basic science into clinical applications , 2013 .
[74] Chibuike C. Udenigwe,et al. Aroma and Taste Perceptions With Alzheimer Disease and Stroke , 2013, Critical reviews in food science and nutrition.
[75] R. Maccioni,et al. Nutraceuticals: a novel concept in prevention and treatment of Alzheimer's disease and related disorders. , 2014, Journal of Alzheimer's disease : JAD.
[76] Shantanu H. Joshi,et al. Higher homocysteine associated with thinner cortical gray matter in 803 participants from the Alzheimer's Disease Neuroimaging Initiative , 2015, Neurobiology of Aging.
[77] M. Battino,et al. Role of plant-based diets in the prevention and regression of metabolic syndrome and neurodegenerative diseases , 2014 .
[78] Eric D. Vidoni,et al. Impaired glycemia increases disease progression in mild cognitive impairment , 2014, Neurobiology of Aging.
[79] K. Yurko-Mauro. Cognitive and cardiovascular benefits of docosahexaenoic acid in aging and cognitive decline. , 2010, Current Alzheimer research.
[80] A. B. Scholey,et al. Improved cognitive performance and mental fatigue following a multi-vitamin and mineral supplement with added guaraná (Paullinia cupana) , 2008, Appetite.
[81] M. Iyo,et al. Positron Emission Tomographic Measurement of Brain Acetylcholinesterase Activity Using N-[11C]methylpiperidin-4-yl Acetate Without Arterial Blood Sampling: Methodology of Shape Analysis and its Diagnostic Power for Alzheimer's Disease , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[82] B. Winblad,et al. Vitamin D in relation to cognitive impairment, cerebrospinal fluid biomarkers, and brain volumes. , 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.
[83] I. Deary,et al. Plasma vitamin C, cholesterol and homocysteine are associated with grey matter volume determined by MRI in non-demented old people , 2003, Neuroscience Letters.
[84] Yemisi Takwoingi,et al. (11)C-PIB-PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). , 2014, The Cochrane database of systematic reviews.
[85] Olivier Salvado,et al. Addressing population aging and Alzheimer's disease through the Australian Imaging Biomarkers and Lifestyle study: Collaboration with the Alzheimer's Disease Neuroimaging Initiative , 2010, Alzheimer's & Dementia.
[86] D. Ingram,et al. Nutrition, Brain Aging, and Neurodegeneration , 2009, The Journal of Neuroscience.
[87] N. Bryan,et al. Food sources of nitrates and nitrites: the physiologic context for potential health benefits. , 2009, The American journal of clinical nutrition.
[88] K. Meguro,et al. Disorders of “taste cognition” are associated with insular involvement in patients with Alzheimer's disease and vascular dementia: “Memory of food is impaired in dementia and responsible for poor diet” , 2014, International Psychogeriatrics.
[89] W H Tsui,et al. Mediterranean Diet and Magnetic Resonance Imaging-Assessed Brain Atrophy in Cognitively Normal Individuals at Risk for Alzheimer's Disease. , 2014, The journal of prevention of Alzheimer's disease.
[90] H. Koek,et al. The influence of vascular risk factors on cognitive decline in patients with dementia: a systematic review. , 2013, Maturitas.
[91] M. Romano,et al. Florbetapir F 18 for brain imaging of β-amyloid plaques. , 2013, Drugs of today.
[92] Michael Weiner,et al. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. , 2010, JAMA.
[93] N. Scarmeas,et al. Diet and Neuroimaging Markers of Cerebrovascular Disease , 2013, Current Nutrition Reports.
[94] Zhichun Chen,et al. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: Implications for diagnostic and therapeutic strategies , 2013, Progress in Neurobiology.
[95] Helgi B. Schiöth,et al. Mediterranean diet habits in older individuals: Associations with cognitive functioning and brain volumes , 2013, Experimental Gerontology.
[96] Maria C. Carrillo,et al. Maximizing the Alzheimer's Disease Neuroimaging Initiative II , 2009, Alzheimer's & Dementia.
[97] C. Annweiler,et al. Nutrient Biomarker Patterns, Cognitive Function, and Mri Measures of Brain Aging , 2012, Neurology.
[98] Yi Li,et al. FDG and Amyloid PET in Cognitively Normal Individuals at Risk for Late-Onset Alzheimer’s Disease , 2014, Advances in molecular imaging.
[99] G. Wenk,et al. Neuropathologic changes in Alzheimer's disease. , 2003, The Journal of clinical psychiatry.
[100] J. Hardy,et al. Amyloid deposition as the central event in the aetiology of Alzheimer's disease. , 1991, Trends in pharmacological sciences.
[101] W. Klunk,et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B , 2004, Annals of neurology.
[102] Sterling C. Johnson,et al. Insulin resistance predicts brain amyloid deposition in late middle-aged adults , 2015, Alzheimer's & Dementia.
[103] N. Herrmann,et al. A functional neuroimaging study of appetite loss in Alzheimer’s disease , 2008, Journal of the Neurological Sciences.